Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chinese red yeast rice is a traditional Chinese product made by fermenting white rice with the mold Monascus purpureus. It has been used for centuries both as a food and in traditional medicine. The fermentation process produces several compounds called monacolins—most notably monacolin K—which is chemically identical to lovastatin, a prescription statin drug used to lower cholesterol. Red yeast rice also contains sterols, isoflavones, and monounsaturated fatty acids that may contribute to its lipid-lowering effects. Its primary indication is for lowering blood cholesterol levels and improving heart health; it has also been proposed for use in reducing triglycerides and possibly preventing heart attacks[1][2][3][7]. However, the content of active ingredients can vary widely between products due to differences in manufacturing processes[4][8]. The US FDA considers products with significant amounts of statin-like compounds as unapproved drugs[2][7]. Side effects are similar to those of statins (muscle pain/weakness, liver toxicity), and some products may be contaminated with citrinin—a nephrotoxic mycotoxin produced during fermentation[1][4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chinese red yeast rice.